Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Sell
1,256
-2,981
-70% -$1.06M 0.03% 319
2025
Q4
$1.39M Sell
4,237
-154
-4% -$48.9K 0.17% 149
2025
Q3
$1.24M Buy
+4,391
New +$1.27M 0.22% 126
2025
Q2
Sell
-730
Closed -$227K 497
2025
Q1
$227K Sell
730
-11,075
-94% -$3.27M 0.02% 432
2024
Q4
$3.08M Buy
+11,805
New +$3.5M 0.35% 87
2023
Q3
Sell
-34,371
Closed -$7.63M 449
2023
Q2
$7.63M Buy
+34,371
New +$7.98M 1.08% 16
2023
Q1
Sell
-10,906
Closed -$2.86M 509
2022
Q4
$2.86M Buy
+10,906
New +$2.92M 0.46% 54
2022
Q1
Sell
-8,722
Closed -$1.96M 501
2021
Q4
$1.96M Buy
8,722
+932
+12% +$197K 0.76% 25
2021
Q3
$1.66M Sell
7,790
-1,032
-12% -$238K 0.42% 74
2021
Q2
$2.15M Buy
8,822
+341
+4% +$83.9K 0.4% 61
2021
Q1
$2.11M Buy
+8,481
New +$2.02M 0.69% 28
2020
Q1
Sell
-10,575
Closed -$2.55M 1018
2019
Q4
$2.55M Buy
+10,575
New +$2.33M 0.26% 99

Other funds holding AMGN

FORA Capital's AMGN Position: Q1 2026 in Review

FORA Capital reduced its Amgen (AMGN) stake by 70% in Q1 2026, selling an estimated $1.06M and leaving 1,256 shares worth $442K. The position accounts for 0.03% of the portfolio, ranked #319.

FORA Capital first reported a position in AMGN in Q4 2019 and has held it in 12 quarters since. The position peaked at $7.63M in Q2 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • FORA Capital held 1,256 shares of Amgen worth $442K as of Q1 2026.
  • FORA Capital sold 2,981 Amgen shares in Q1 2026, an estimated $1.06M.
  • Amgen made up 0.03% of FORA Capital's portfolio in Q1 2026, its #319 holding.
  • FORA Capital first reported a position in Amgen in Q4 2019 and has held it in 12 quarters since.
  • FORA Capital's Amgen position peaked at $7.63M in Q2 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.